Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 3Phase EARLY_PHASE1 2Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Stomatitis 1Neoplasms 1Lymphedema 1Disease 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Methylene Blue × Clear all
NCT03469284 2023-04-25

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

M.D. Anderson Cancer Center

Phase 2 Completed
69 enrolled 11 charts

Neoplasms, Stomatitis

NCT01276054 2014-08-01

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

University of Southern California

Phase 2 Terminated
4 enrolled 8 charts
Breast

Breast Neoplasms, Lymphedema

NCT00784849 2012-06-20

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed
62 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡